Location History:
- San Luis Obispo, CA (US) (2002 - 2003)
- Belmont, CA (US) (2003)
Company Filing History:
Years Active: 2002-2003
Title: Wayne D. Inman: Innovator in Hypoglycemic and Hypotriglyceridemic Compounds
Introduction
Wayne D. Inman is a notable inventor based in San Luis Obispo, CA. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that have hypoglycemic and hypotriglyceridemic properties. With a total of 3 patents to his name, Inman's work is paving the way for advancements in dietary supplements and treatments for metabolic conditions.
Latest Patents
Inman’s latest patents include innovative compositions that utilize isolated or purified stilbenoid compounds. One of his patents focuses on the use of these compounds, including longistyline A-2-carboxylic acid, as hypoglycemic agents to lower serum glucose levels. This invention also explores the potential of combining these stilbenoid compounds with other hypoglycemic agents for enhanced efficacy. Another patent describes methods for using these compounds as dietary supplements for mammals suffering from elevated triglyceride levels, again highlighting the potential for combination with other hypotriglyceridemic agents.
Career Highlights
Wayne D. Inman is currently associated with Insmed Incorporated, a company that focuses on innovative therapies for serious diseases. His work at Insmed has allowed him to further explore the applications of his patented compounds in clinical settings. Inman’s dedication to research and development has positioned him as a key figure in the advancement of treatments for metabolic disorders.
Collaborations
Inman collaborates with David C. Hopp, contributing to the innovative research environment at Insmed Incorporated. Their combined expertise enhances the potential for groundbreaking discoveries in the field of biochemistry.
Conclusion
Wayne D. Inman is a distinguished inventor whose work on hypoglycemic and hypotriglyceridemic compounds is making a significant impact in the medical field. His contributions through patents and collaborations are paving the way for new treatments that could benefit many individuals suffering from metabolic conditions.